PDF《past 15 years》

15 years since its introduction clear informa- tion becomes visible. Major changes have occurred concerning donor type, stem cell source, indications and technology. This is re?ected in this 15th survey, which includes presentation of the

2004 data. Patients and methods Data collection and validation All participating teams reported their data for

2004 by indication, stem cell source and donor type as listed in Table 1. Data were validated by the reporting team, which received a computer printout of entered data, and by crosschecking with national registries. Onsite visits of selected teams were part of the quality control program. Received

7 March 2006;

accepted

20 March

2006 Correspondence: Dr A Gratwohl, Division of Hematology, Department of Internal Medicine, University Hospital Basel, Petersgraben 4, Basel CH C 4031, Switzerland. E-mail: [email protected] Bone Marrow Transplantation (2006) 37, 1069C1085 &

2006 Nature Publishing Group All rights reserved 0268-3369/06 $30.00 www.nature.com/bmt Teams For the

2004 report,

612 teams in

43 participating countries were contacted of which

592 reported their numbers. This corresponds to a 97% return rate of active teams and includes

481 of the

494 active EBMT member teams reporting to the survey. Twenty teams known by the investigators to have been performing HSCT in

2004 were also contacted, but chose not to reply or, for unknown reasons, failed to reply in spite of several efforts to reach them. No major transplant team in Europe is missing from this list. Contacted teams are listed in the Appendix A in alphabetical order accordi........